Cargando…
Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies
Cadherin-11 (CDH11), associated with epithelial to mesenchymal transformation in development, poor prognosis malignancies and cancer stem cells, is also a major therapeutic target in rheumatoid arthritis (RA). CDH11 expressing basal-like breast carcinomas and other CDH11 expressing malignancies exhi...
Autores principales: | Assefnia, Shahin, Dakshanamurthy, Sivanesan, Auvil, Jaime M. Guidry, Hampel, Constanze, Anastasiadis, Panos Z., Kallakury, Bhaskar, Uren, Aykut, Foley, David W, Brown, Milton L., Shapiro, Lawrence, Brenner, Michael, Haigh, David, Byers, Stephen W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039224/ https://www.ncbi.nlm.nih.gov/pubmed/24681547 |
Ejemplares similares
-
Retinoic Acid Mediates Regulation of Network Formation by COUP-TFII and VE-Cadherin Expression by TGFβ Receptor Kinase in Breast Cancer Cells
por: Prahalad, Priya, et al.
Publicado: (2010) -
ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening
por: Issa, Naiem T., et al.
Publicado: (2022) -
Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
por: Gay, Martha D., et al.
Publicado: (2022) -
Small molecule selected to disrupt oncogenic protein EWS-FLI1 interaction with RNA Helicase A inhibits Ewing's Sarcoma
por: Erkizan, Hayriye V., et al.
Publicado: (2009) -
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing
por: Issa, Naiem T., et al.
Publicado: (2016)